Tuesday, 02 January 2024 12:17 GMT

Orogen Royalties Inc.


(MENAFN- Baystreet) 10:07 AM EST - Orogen Royalties Inc. : Announces that, as part of the Company's annual share-based compensation program, the Board of Directors have authorized a grant of 324,000 Restricted Share Units (RSUs), 62,000 Deferred Share Units (DSUs), and 977,000 incentive Stock Options to directors, officers, employees, and consultants. The grant has been authorized pursuant to the Company's Omnibus Equity Incentive Compensation Plan that was approved by shareholders October 29, 2024. Orogen Royalties Inc. shares V are trading unchanged at $1.51.

MENAFN01022025000212011056ID1109155519


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.